Intravenous thrombolytic therapy in acute stroke

Vascular Medicine

Volumn 2, Issue 1, 1997, Pages 51-60

  Tong, David C ^a,b   Yenari, Midori A ^a   Albers, Greg W ^a  

^a STANFORD UNIVERSITY MEDICAL CENTER   (United States)

^b Stanford California and Cofounder   (United States)

Author keywords

Acute stroke; Thrombolysis; Treatment

Indexed keywords

6 NITRO 7 SULFAMOYLBENZO[F]QUINOXALINE 2,3 DIONE; ACETYLSALICYLIC ACID; ALTEPLASE; AMPA RECEPTOR; ANTICOAGULANT AGENT; ANTITHROMBOCYTIC AGENT; FIBRINOLYTIC AGENT; HEPARIN; INTERCELLULAR ADHESION MOLECULE 1; N METHYL DEXTRO ASPARTIC ACID RECEPTOR; PLACEBO; STREPTOKINASE; TISSUE PLASMINOGEN ACTIVATOR; UROKINASE;

BRAIN HEMORRHAGE; CLINICAL PROTOCOL; CLINICAL TRIAL; COMPUTER ASSISTED TOMOGRAPHY; DRUG CONTRAINDICATION; DRUG EFFICACY; FIBRINOLYTIC THERAPY; FOOD AND DRUG ADMINISTRATION; HUMAN; INTRAARTERIAL DRUG ADMINISTRATION; INTRAVENOUS DRUG ADMINISTRATION; NONHUMAN; ORAL DRUG ADMINISTRATION; PATIENT SELECTION; PRACTICE GUIDELINE; PRIORITY JOURNAL; REVIEW; RISK BENEFIT ANALYSIS; STROKE; ARTICLE; BLEEDING; BRAIN FUNCTION; BRAIN INFARCTION SIZE; BRAIN INJURY; CAUSE OF DEATH; CEREBROVASCULAR ACCIDENT; CLINICAL TRIAL (TOPIC); COMBINATION CHEMOTHERAPY; DRUG DESIGN PROGRAM; DRUG SAFETY; HEART INFARCTION; HEMATOMA; HIGH RISK PATIENT; HYPERTENSION; HYPOTHERMIA; LASER DOPPLER FLOWMETRY; MONOTHERAPY; MORBIDITY; MORTALITY; MULTICENTER STUDY (TOPIC); NEUROPROTECTION; NUCLEAR MAGNETIC RESONANCE IMAGING; ONSET AGE; RISK FACTOR; TREATMENT DURATION;

EID: 0030791458     PISSN: 1358863X     EISSN: None     Source Type: Journal    
DOI: 10.1177/1358863X9700200108     Document Type: Review

References (15)

1. A H A. Heart and stroke facts. Bethesda, MD: American Heart Association, 1992: 7.
2. Mohr J, Caplan L, Melski J et al. The Harvard cooperative stroke registry: a prospective registry. Neurology 1978; 28: 754-62.
3. Levine SR, Brott TG. Thrombolytic therapy in cerebrovascular disorders. Prog Cardiovasc Dis 1992; 34(4): 235-62.
4. Overgaard K, Sereghy T, Boysen G, Pedersen H, Hoyer S, Diemer NH. A rat model of reproducible cerebral infarction using thrombotic blood clot emboli. J Cereb Blood Flow Metab 1992; 12(3): 484-90.
5. Kissel P, Chehrazi B, Seibert JA, Wagner F Jr. Digital angiographic quantification of blood flow dynamics in embolic stroke treated with tissue-type plasminogen activator. J Neurosurg 1987; 67(3): 399-405.
6. Chehrazi BB, Seibert JA, Kissel P, Hein L, Brock JM. Evaluation of recombinant tissue plasminogen activator in embolic stroke. Neurosurgery 1989; 24(3): 355-60.
7. Phillips DA, Davis MA, Fisher M. Selective embolization and clot dissolution with tPA in the internal carotid artery circulation of the rabbit. Am J Neuroradiol 1988; 9(5): 899-902.
8. Russell D, Madden KP, Clark WM, Zivin JA. Tissue plasminogen activator cerebrovascular thrombolysis in rabbits is dependent on the rate and route of administration. Stroke 1992; 23(3): 388-93.
9. Bednar MM, McAuliffe T, Raymond S, Gross CE. Tissue plasminogen activator reduces brain injury in a rabbit model of thromboembolic stroke. Stroke 1990; 21(12): 1705-709.
10. Overgaard K, Sereghy T, Boysen G, Pedersen H, Diemer NH. Reduction of infarct volume and mortality by thrombolysis in a rat embolic stroke model. Stroke 1992; 23(8): 1167-73.
11. Thomas GR, Thibodeaux H, Bennett WF et al. Optimized thrombolysis of cerebral clots with tissue-type plasminogen activator in a rabbit model of embolic stroke. J Pharmacol Exp Ther 1993; 264(1): 67-73.
12. de Crespigny AJ, Tsuura M, Moseley ME, Kucharczyk J. Perfusion and diffusion MR imaging of thromboembolic stroke. J Magn Reson Imaging 1993; 3(5): 746-54.
13. Zivin JA, Fisher M, DeGirolami U, Hemenway CC, Stashak JA. Tissue plasminogen activator reduces neurological damage after cerebral embolism. Science 1985; 230(4731): 1289-92.
14. Zivin JA, Lyden PD, DeGirolami U et al. Tissue plasminogen activator. Reduction of neurologic damage after experimental embolic stroke. Arch Neurol 1988; 45(4): 387-91.
15. Zivin JA, Mazzarella V. Tissue plasminogen activator plus glutamate antagonist improves outcome after embolic stroke. Arch Neurol 1991; 48(12): 1235-38.